CORC

浏览/检索结果: 共20条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Dexamethasone combined with berberine is an effective therapy for bleomycin-induced pulmonary fibrosis in rats 期刊论文
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 卷号: 18, 期号: 4
作者:  Shen, Yanhua;  Liu, Fangying;  Ma, Wei;  Wang, Zhongfu;  Wei, Lei
收藏  |  浏览/下载:42/0  |  提交时间:2019/12/05
Mechanism of Cxc Chemokine Ligand 5 (CXCL5)/Cxc Chemokine Receptor 2 (CXCR2) Bio-Axis in Mice with Acute Respiratory Distress Syndrome 期刊论文
MEDICAL SCIENCE MONITOR, 2019, 卷号: 25
作者:  Wang, Chang-yong;  Shang, Min;  Zhou, Chen-liang;  Feng, Li-zhi;  Zhou, Qing-shan
收藏  |  浏览/下载:21/0  |  提交时间:2019/12/05
CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target. 期刊论文
Clinica chimica acta, international journal of clinical chemistry, 2019, 卷号: 495, 页码: 538-544
作者:  Gao, Jia-Hui;  Yu, Xiao-Hua;  Tang, Chao-Ke*
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/27
Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents 期刊论文
ROYAL SOCIETY OPEN SCIENCE, 2018, 卷号: 5, 期号: 7
作者:  Che, Jinxin;  Wang, Zhilong;  Sheng, Haichao;  Huang, Feng;  Dong, Xiaowu
收藏  |  浏览/下载:42/0  |  提交时间:2019/01/08
The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 149, 页码: 148-169
作者:  Peng, Dian;  Cao, Bin;  Zhou, Ying-Jun;  Long, Ya-Qiu
收藏  |  浏览/下载:39/0  |  提交时间:2019/01/08
High CXC Chemokine Ligand 16 (CXCL16) Expression Promotes Proliferation and Metastasis of Lung Cancer via Regulating the NF-kappa B Pathway 期刊论文
MEDICAL SCIENCE MONITOR, 2018, 卷号: 24
作者:  Liang, Kun;  Liu, Yanru;  Eer, Dun;  Liu, Jingbin;  Yang, Fan
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis 期刊论文
The International Journal of Biochemistry & Cell Biology, 2015, 卷号: 67, 页码: 92-100
作者:  Luo, Yangyang;  Wang, Yong;  Shu, Ye;  Lu, Qianjin;  Xiao, Rong*
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/03
SSc  systemic sclerosis  SRC  scleroderma renal crisis  PAH  pulmonary arterial hypertension  SMR  standardized mortality ratio  DNMTs  DNA methyltransferases  SAM  S-adenosyl-methionine  5mC  5-methylcytosine  MBD  methyl-CpG-binding domain  Tet  ten–eleven translocation  HATs  histone acetyltransferases  HDACs  histone deacetylases  MiRNAs  microRNAs  MZ  monozygotic  DZ  dizygotic  MVECs  microvascular endothelial cells  FBs  fibroblasts  JAMs  junctional adhesion molecules  CTGF  connective tissue growth facto  TGF-β  transforming growth factor beta  CCN2  connective tissue growth factor  Fli1  Friend leukemia integration-1  TF  transcription factor  PECAM  platelet/endothelial cell adhesion molecule  PDGF  platelet derived growth factor  S1P1  sphingosin 1 phosphate  CXCL5  CXC chemokine ligand-5  BMPs  bone morphogenetic proteins  BMPRII  bone morphogenetic protein type II receptor  ET-1  endotheline-1  uPA  urokinase-type plasminogen activator  MBD  methyl-CpG-binding domain protein  ICAM  intercellular adhesion molecule  KLF5  Kruppel-like factor 5  Tregs  regulatory T cells  Runx1  Runt-related transcription factor 1  FOXP3  forkhead box protein 3 gene  ECM  extra cellular matrix  PDGF  platelet-derived growth factor  dSSc  diffuse systemic sclerosis  lSSc  limited systemic sclerosis  PCAF  protein-associated factor  Egr-1  early growth response 1  DDR2  discoidin domain receptor 2  TAB1  TGF-β activated kinase 1 binding protein 1  BAFF  B cell-activating factor  TSP-2  thrombospondin-2  MRTSS  Modified Rodnan total skin score  SDAI  Valentini scleroderma disease activity index  HC  healthy controls  SLE  systemic lupus erythematosus  SSD  scleroderma spectrum disorder  MTX  methylaminopterin  CYC  cyclophosphamide  MMF  mycophenolate mofetil  ACE  angiotensin converting enzyme  NO  nitric oxide  Systemic sclerosis  Epigenetic mechanisms  Biomarker  Therapy  
Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 卷号: 33
作者:  Zhao, Shengqiang;  Wang, Jing;  Qin, Chengyong
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/17
Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension 期刊论文
2014, 卷号: 43, 期号: 4, 页码: 322-327
作者:  Yang, Tao;  Li, Zhen-Nan;  Chen, Guo;  Gu, Qing;  Ni, Xin-Hai
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/13
Interleukin-17A in lipid metabolism and atherosclerosis 期刊论文
Clinica Chimica Acta, 2014, 卷号: 431, 页码: 33-39
作者:  Yu, Xiao-Hua;  Jiang, Na;  Zheng, Xi-Long;  Cayabyab, Francisco S;  Tang, Zhi-Bin*
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/27
IL-17  interleukin-17  Th17  T helper 17  IL-17R  IL-17 receptor  STAT3  signal transducer and activator of transcription 3  RORγ  retinoic acid receptor-related orphan receptor γ  IRF4  interferon regulatory factor 4  ERK  extracellular signal-regulated kinase  Ets1  E26 transformation-specific 1  15(S)-HETE  15(S)-hydroxyeicosatetraenoic acid  SF1  alternative splicing factor  MAPK  mitogen-activated protein kinase  PPARγ  peroxisome proliferator-activated receptor γ  TRAF  tumor necrosis factor receptor-associated factor  TAK1  transforming growth factor-β-activated kinase 1  TAB  TAK1-binding protein  IKK  IκB kinase  NF-κB  nuclear factor kappa-B  IKKi  inducible IKK  JNK  c-Jun N-terminal kinase  C/EBP  CCAAT/enhancer-binding protein  AP1  activator protein 1  USP  ubiquitin-specific protease  CXCL  CXC chemokine ligand  ASF  alternative splicing factor  Hsp90  heat shock protein 90  RCT  reverse cholesterol transport  ABCA1  ATP-binding cassette transporter A1  apo E  apolipoprotein E  LDLR  low-density lipoprotein receptor  FABP4  fatty acid-binding protein-4  IL-17A  IL-17RA  IL-17RC  Lipid metabolism  Atherosclerosis  


©版权所有 ©2017 CSpace - Powered by CSpace